Jack Lasersohn Net Worth & Insider Trades

Jack Lasersohn - Director, Oncomed Pharmaceuticals Inc

As of June 25, 2018

What is Jack Lasersohn's Net Worth?

The current estimated net worth of Oncomed Pharmaceuticals Inc's Director, Jack Lasersohn, is estimated to be about $134.41M . Jack Lasersohn owns about 566,008 units of Oncomed Pharmaceuticals Inc common stock. In the last 3 years at Oncomed Pharmaceuticals Inc, Jack Lasersohn has sold an estimated value of $0 worth.

What is Jack Lasersohn's Past Insider Trading?

Jack Lasersohn's largest purchase order was 13,140 units , worth over $191.78K on September 30, 2015. In total, Jack Lasersohn has made about 17 transactions over 3 years of their time at Oncomed Pharmaceuticals Inc. Jack Lasersohn usually trades in June, with the busiest year in 2015. The most recent transaction was a purchase order of 34,614 units , worth over $116.64K on May 26, 2017.

Jack W Lasersohn

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Jack Lasersohn's' Mailing Address?

  • Mailing address is 18 Bank Street Summit NJ 07901 NJ

Oncomed Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Total
John A. Lewicki, Ph.D., 2017 $419,777 $192,925 $967,675 $167,911 $1,748,288
John A. Lewicki, Ph.D., 2016 $407,550 $141,750 - $146,718 $696,018
Paul Hastings, 2017 $551,127 $169,650 $1,857,110 $60,624 $2,638,511
Paul Hastings, 2016 $535,075 $158,760 - $264,862 $958,697
Sunil Patel, 2017 $406,117 $183,600 $939,700 $167,780 $1,697,197
Austin Gurney, Ph.D., 2017 $365,612 $154,536 $804,964 $116,996 $1,442,108
Alicia Hager, J.D., Ph.D., 2017 $347,619 $154,536 $804,964 $125,143 $1,432,262
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1302573/000156459018009577/omed-def14a_20180622.htm

What are Oncomed Pharmaceuticals Inc's Past Insider Trades?

Oncomed Pharmaceuticals Inc's most recent insider trade came on December 26, 2018 by Austin Gurney who sold 11,117 units worth $6.67K . In the last 5 years, insiders at Oncomed Pharmaceuticals Inc have sold an estimated value of $14.76M and bought an estimated value of $23.88M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Austin Gurney, See Remarks,  John A Lewicki, President and CEO,  and Alicia J Hager, SVP and General Counsel .

OncoMed Pharmaceuticals Inc Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1